| Literature DB >> 29167684 |
Fereshteh Baghai Naini1, Pouyan Aminishakib2, Maedeh Ghorbanpour3, Mohammad Mehdi Vakili4, Mohammad Javad Kharazifard5.
Abstract
OBJECTIVES: The frequency of non-odontogenic lesions of the jawbones is lower than that of odontogenic lesions; however, study of the epidemiologic data of these lesions is required for health care programs. This study aimed to assess the relative frequency and demographic profile of non-odontogenic jaw lesions in an Iranian population over a 30-year period.Entities:
Keywords: Jaw; Nonodontogenic Cysts; Prevalence; Retrospective Studies
Year: 2017 PMID: 29167684 PMCID: PMC5694845
Source DB: PubMed Journal: J Dent (Tehran) ISSN: 1735-2150
Frequency and demographic data of each group of lesions
| 64 (6.6) | 0 (0.0) | 24 (37.5) | 40 (62.5) | 64 (100.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | |
| 779 (80.1) | 9 (1.1) | 453 (58.1) | 317 (40.7) | 252 (32.3) | 474 (60.8) | 3 (0.3) | 50 (6.4) | |
| 129 (13.3) | 2 (1.5) | 72 (55.8) | 55 (42.6) | 31 (24.03) | 92 (71.3) | 0(0.0) | 6 (4.6) | |
| 972 (100.0) | 11 (1.1) | 549 (56.4) | 412 (42.3) | 346 (35.6) | 566 (58.2) | 3 (0.3) | 57 (5.8) | |
NS= Not specified; Max.= Maxilla; Man.= Mandible
Frequency of cystic lesions and their distribution according to gender, age and location
| 48 (75.0) | 0 (0.0) | 18 (37.5) | 30 (62.5) | 39.5 | 48 (100.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | |
| 16 (25.0) | 0 (0.0) | 6 (37.5) | 10 (62.5) | 44.9 | 16 (100.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | |
| 64 (100.0) | 0 (0.0) | 24 (37.5) | 40 (62.5) | 64 (100.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | ||
NS= Not specified; Max.= Maxilla; Man.= Mandible
Frequency of tumors and tumor-like lesions and their distribution according to gender, age and location
| NS (%) | Female (%) | Male (%) | Max. (%) | Man. (%) | Both (%) | NS (%) | |||
|---|---|---|---|---|---|---|---|---|---|
| 341 (43.7) | 7 (2.05) | 216 (63.3) | 118 (34.6) | 25.47 | 107 (31.3) | 216 (63.3) | 0 (0.0) | 18 (5.2) | |
| 95 (12.2) | 0 (0.0) | 59 (62.1) | 36 (37.8) | 29.16 | 23 (24.2) | 63 (66.3) | 0 (0.0) | 9 (9.4) | |
| 53 (6.8) | 0 (0.0) | 31 (58.5) | 22 (41.5) | 22.36 | 12 (22.6) | 39 (73.5) | 0 (0.0) | 2 (3.77) | |
| 51 (6.5) | 1 (1.9) | 40 (78.4) | 10 (19.6) | 31.16 | 16 (31.3) | 31 (60.7) | 1 (1.9) | 3 (5.8) | |
| 34 (4.3) | 0 (0.0) | 9 (26.4) | 25 (73.5) | 18.96 | 11 (32.3) | 18 (52.9) | 0 (0.0) | 5 (14.7) | |
| 27 (3.4) | 0 (0.0) | 6 (22.2) | 21 (77.7) | 35.98 | 17 (62.9) | 9 (33.3) | 0 (0.0) | 1 (3.7) | |
| 27 (3.4) | 0 (0.0) | 16 (59.2) | 11 (40.7) | 33.56 | 11 (40.7) | 11 (40.7) | 0 (0.0) | 5 (18.5) | |
| 25 (3.2) | 1 (4.0) | 12 (48.0) | 12 (48.0) | 25.30 | 17 (68.0) | 6 (24.0) | 0 (0.0) | 2 (8.0) | |
| 25 (3.2) | 0 (0.0) | 10 (40.0) | 15 (60.0) | 28.66 | 9 (36.0) | 16 (64.0) | 0 (0.0) | 0 (0.0) | |
| 11 (1.4) | 0 (0.0) | 10 (90.9) | 1 (9.1) | 41.33 | 2 (18.1) | 9 (81.8) | 0 (0.0) | 0 (0.0) | |
| 10 (1.2) | 0 (0.0) | 8 (80.0) | 2 (20.0) | 30.9 | 0 (0.0) | 9 (90.0) | 0 (0.0) | 1 (10.0) | |
| 80 (10.2) | 0 (0.0) | 36 (45.0) | 44 (55.0) | 27 (33.75) | 47 (58.75) | 2 (2.5) | 4 (5.0) | ||
| 779 (100.0) | 9 (1.1) | 453 (58.1) | 317 (40.7) | 252 (32.3) | 474 (60.8) | 3 (0.3) | 50 (6.4) | ||
CGCG: Central giant cell granuloma; NS= not specified; Max.= Maxilla; Man.= Mandible
Cherubism (n=9); small round cell sarcoma (n=9); spindle cell sarcoma (n=9); chondrosarcoma (n= 8); plasmacytoma (n=7); central mucoepidermoid carcinoma (n=4); ewing’s sarcoma (n=4); juvenile ossifying fibroma (n=4); osteoblastoma (n=3); adenocarcinoma (n=2); cavernous hemangioma (n=2); desmoplastic fibroma (n=2); intraosseous squamous cell carcinoma (n=2); metastatic carcinoma (n= 2); neurofibroma (n= 2); osteoid osteoma (n= 2); benign myxoid tumor (n=1); chondroblastoma (n=1); chondroma (n=1); gigantiform cementoma (n=1); hemangioma (n=1); high grade spindle cell sarcoma (n=1); mature teratoma (n=1); osteochondroma (n=1); solitary plasmacytoma (n=1)
Frequency of infectious/inflammatory/reactive lesions and their distribution according to gender, age and location
| NS (%) | Female (%) | Male (%) | Max. (%) | Man. (%) | Both (%) | NS (%) | |||
|---|---|---|---|---|---|---|---|---|---|
| 83 (64.3) | 1 (1.20) | 39 (46.9) | 43 (51.8) | 38.2 | 24 (28.9) | 55 (66.2) | 0 (0.0) | 4 (4.8) | |
| 25 (19.3) | 1 (4.0) | 20 (80.0) | 4 (16) | 20.69 | 0 (0.0) | 24 (96.0) | 0 (0.0) | 1 (4.0) | |
| 7 (5.4) | 0 (0.0) | 4 (57.1) | 3 (42.8) | 33.66 | 3 (42.8) | 4 (57.1) | 0 (0.0) | 0 (0.0) | |
| 6 (4.6) | 0 (0.0) | 4 (66.6) | 2 (33.3) | 37.83 | 1 (16.6) | 5 (83.3) | 0 (0.0) | 0 (0.0) | |
| 4 (3.1) | 0 (0.0) | 3 (75.0) | 1 (25.0) | 47.25 | 1 (25.0) | 2 (50.0) | 0 (0.0) | 1 (25.0) | |
| 2 (1.5) | 0 (0.0) | 2 (100.0) | 0 (0.0) | 20.00 | 2 (100.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | |
| 1 (0.7) | 0 (0.0) | 0 (0.0) | 1 (100.0) | 14.00 | 0 (0.0) | 1 (100.0) | 0 (0.0) | 0 (0.0) | |
| 1 (0.7) | 0 (0.0) | 0 (0.0) | 1 (100.0) | 43.00 | 0 (0.0) | 1 (100.0) | 0 (0.0) | 0 (0.0) | |
| 129 (100.0) | 2 (1.5) | 72 (55.8) | 55 (42.6) | 31 24.03) | 92 (71.3) | 0 (0.0) | 6 (4.6) | ||
NS= Not specified; Max.= Maxilla; Man.= Mandible